...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Biogen/Eisai Scrap Aducanumab

We may not know how many of the 467 patients with mild cognitive impairment enrolled in the BOM that underwent MoCA actually suffer from vascular dementia. Or does it really matter if the MoCA scores are much improved from baseline to final adjudication of the BOM trial in this regard?

 

Koo

Share
New Message
Please login to post a reply